Market Place
Sourcing Support
Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
02 Dec 2021 //
BUSINESSWIRE
Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
23 Nov 2021 //
BUSINESSWIRE
FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus
08 Oct 2021 //
ENDPTS
Enforcement Report - Week of January 16, 2019
16 Jan 2019 //
FDA
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
DOJ`s price-fixing investigation could lead to sizable liabilities, analyst says
10 Nov 2016 //
FIERCE PHARMA
Despite Drug Trial Failure, Are Chimerix Shares Due For A Rebound?
31 Dec 2015 //
FORBES
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.